Search
Search
We’re ready to empower your expertise with innovative solutions for infectious diseases to boost workflow efficiency, help fight antimicrobial resistance (AMR) and guide effective outcomes.
Discover a range of innovative solutions to address major health challenges across sectors, including the emergence of pathogens, antimicrobial resistance and environmental surveillance at ASM Microbe 2026.
Reliable diagnosis begins with reliable culture. Visit our booth to explore our comprehensive culture media portfolio, including our new and improved formulation of Thermo Scientific Brilliance Candida 2 Agar, designed to deliver clearer detection and differentiation of clinically relevant Candida species, including direct identification of Candida auris. Learn more at our culture media page
Critical decisions demand accurate MIC determination. Join us at ASM Microbe to discover how the Thermo Scientific Sensititre portfolio supports laboratories in the fight against antimicrobial resistance. Our team will be available to discuss how our AST solutions integrate seamlessly into your workflow and support your stewardship goals.
Rapid microbial identification (RMID) in as little as 24 hours with targeted next-generation sequencing (NGS). Pan-bacterial and pan-fungal metagenomic detection, along with species-specific identification of 88 microbial species all in a single assay.
Take advantage of dedicated time with our product experts.
Whether you’d like to discuss specific applications, explore new developments, review ongoing projects, or gain insight into our latest innovations, stop by for an informal conversation or schedule a focused discussion - we look forward to connecting with you.
Mandi Kulwicki
AST, Sensititre System
Megan McKinney
Culture Media
Dylan Staats
Research & Development
Candida auris: What Every Laboratory Needs to Know About Identification, Resistance, and Treatment
Saturday, June 6 1:00 PM, Theater B
Speakers:
Nathan A. Ledeboer, Professor and Chief, Division of Clinical Pathology, Department of Pathology, Medical College of Wisconsin
Jerod Nagel, PharmD, FIDSA, Pharmacy Lead, Infectious Diseases & Antimicrobial Stewardship, Co-Director, ID fellowship, Clinical Assistant Instructor, Michigan Medicine, University of Michigan, College of Pharmacy
From Dysbiosis to Data: Harnessing Rapid NGS to Decode Oral Microbial Communities
Sunday, June 7th 11:00 AM, Theater A
Speaker:
Hadeel Ayoub, PhD, MSDH, LDH, Senior Research Associate and Lead Microbiologist, Therametric Technologies, Inc.
*For Research Use Only. Not for use in diagnostic procedures.
**For In Vitro Diagnostic Use.
Products are distributed globally so uses, applications, and availability of product in each country depend on local regulatory marketing authorization status.
Products are distributed globally so uses, applications, and availability of product in each country depend on local regulatory marketing authorization status.